Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

US OKs retinal diseases and glaucoma laser:

This article was originally published in Clinica

Executive Summary

The US FDA has given Nidek the go-ahead to market its DC-3300 diode laser system for uses in retinal photocoagulation and glaucoma procedures. The flexibility of the DC-3300 allows retinal treatment for diabetic retinopathy and macular degeneration as well as glaucoma procedures such as laser trabeculoplasty and iridotomy, says the Fremont, California firm. The device can be used in combination with various delivery systems, such as slit lamps, binocular indirect ophthalmoscopes, and endoprobes.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT064921

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel